A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells." ...
Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback